Literature DB >> 22081376

COX-2 and survivin reduction may play a role in berberine-induced apoptosis in human ductal breast epithelial tumor cell line.

Yaghub Pazhang1, Shahin Ahmadian, Nader Javadifar, Mahshid Shafiezadeh.   

Abstract

Berberine is an isoquinoline alkaloid that has several pharmacological effects such as antiinflammatory, antimicrobial, apoptosis-inducing and anticancer effects. It has been illustrated that the antiinflammatory effect is mediated by suppressing the nuclear factor-kappa B (NF-κB) that activates expression of some antiinflammatory and antiapoptotic proteins including cyclooxygenase-2(COX-2), inducible nitric oxide synthase (iNOS) and survivin; therefore, berberine may induce apoptosis by reducing antiinflammatory and antiapoptotic agents, which suggest the relationship between antiinflammatory and apoptosis pathways. For further illustration of the mechanism of berberine action, the human ductal breast epithelial tumor cell line (T47D cell line) was treated with different concentrations of berberine (25-100 μM/ml). Berberine in 50 μM/ml had the most reducing effect on cell viability and inducing of apoptosis. The level of COX-2, iNOS and survivin proteins decreased in berberine-treated cells; however, treatment of the cells with aspirin and aminoguanidine (AG), COX-2 and iNOS inhibitors, respectively, showed that despite the cell growth-reducing effect of aspirin, AG did not have a significant effect on cell viability. On the other hand, with the attention to reduction in survivin protein level in berberine-treated cells, the results suggest that the apoptotic effect of berberine may be mediated by reduction in both of the COX-2 and survivin in T47D cell line, while the iNOS does not play any effective role in berberine-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22081376     DOI: 10.1007/s13277-011-0263-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  33 in total

Review 1.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

Review 2.  Nitric oxide synthases: roles, tolls, and controls.

Authors:  C Nathan; Q W Xie
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

3.  Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells.

Authors:  J-M Hwang; H-C Kuo; T-H Tseng; J-Y Liu; C-Y Chu
Journal:  Arch Toxicol       Date:  2005-09-28       Impact factor: 5.153

4.  Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue.

Authors:  M Kojima; T Morisaki; Y Tsukahara; A Uchiyama; Y Matsunari; R Mibu; M Tanaka
Journal:  J Surg Oncol       Date:  1999-04       Impact factor: 3.454

5.  Significance of nitric oxide in carcinogenesis, tumor progression and cancer therapy.

Authors:  P K Lala
Journal:  Cancer Metastasis Rev       Date:  1998-03       Impact factor: 9.264

6.  Inducible nitric oxide synthase and cyclooxgenase-2 mediate protection of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress in PC12 cells.

Authors:  Xiao-qing Tang; Hui-min Yu; Jun-li Zhi; Yu Cui; Er-hu Tang; Jian-qiang Feng; Pei-xi Chen
Journal:  Life Sci       Date:  2006-03-20       Impact factor: 5.037

7.  The role of COX-2 inhibitors in lung cancer.

Authors:  Syed Suhail Ahmed Qadri; Jiag Huai Wang; Karen Christina Redmond; Aonghus F O' Donnell; Thomas Aherne; Henry Paul Redmond
Journal:  Ann Thorac Surg       Date:  2002-11       Impact factor: 4.330

8.  Aminoguanidine impedes human pancreatic tumor growth and metastasis development in nude mice.

Authors:  Nora A Mohamad; Graciela P Cricco; Lorena A Sambuco; Máximo Croci; Vanina A Medina; Alicia S Gutiérrez; Rosa M Bergoc; Elena S Rivera; Gabriela A Martín
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

Review 9.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.

Authors:  Alexander Greenhough; Helena J M Smartt; Amy E Moore; Heather R Roberts; Ann C Williams; Christos Paraskeva; Abderrahmane Kaidi
Journal:  Carcinogenesis       Date:  2009-01-09       Impact factor: 4.944

10.  Nitric oxide synthase activity in human breast cancer.

Authors:  L L Thomsen; D W Miles; L Happerfield; L G Bobrow; R G Knowles; S Moncada
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more
  8 in total

Review 1.  Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Shilu Mathew; Hany Abdel-Hafiz; Abbas Raza; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-08

2.  Mesalazine induces apoptosis via mitochondrial pathway in K562 cell line.

Authors:  Parisa Forsati; Yaghub Pazhang
Journal:  Vet Res Forum       Date:  2022-03-15       Impact factor: 0.950

3.  The association between cyclooxygenase-2 1195 G/A polymorphism and hepatocellular carcinoma: evidence from a meta-analysis.

Authors:  Xianmin Bu; Chenghai Zhao
Journal:  Tumour Biol       Date:  2013-03-14

4.  Effects of berberine on proliferation, cell cycle distribution and apoptosis of human breast cancer T47D and MCF7 cell lines.

Authors:  Elmira Barzegar; Shamileh Fouladdel; Tahereh Komeili Movahhed; Shekoufeh Atashpour; Mohammad Hossein Ghahremani; Seyed Nasser Ostad; Ebrahim Azizi
Journal:  Iran J Basic Med Sci       Date:  2015-04       Impact factor: 2.699

5.  The association between three cyclooxygenase-2 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.

Authors:  Zhigang Chen; Jiye Zhu; Chaoyuan Huang; Fang Lian; Guobin Wu; Yinnong Zhao
Journal:  PLoS One       Date:  2015-03-02       Impact factor: 3.240

Review 6.  Berberine as a potential agent for breast cancer therapy.

Authors:  Xiao-Dan Zhong; Li-Juan Chen; Xin-Yang Xu; Yan-Jun Liu; Fan Tao; Ming-Hui Zhu; Chang-Yun Li; Dan Zhao; Guan-Jun Yang; Jiong Chen
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

7.  The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer.

Authors:  Anuj Suri; Xiugui Sheng; Kevin M Schuler; Yan Zhong; Xiaoyun Han; Hannah M Jones; Paola A Gehrig; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Oncotarget       Date:  2016-06-28

Review 8.  Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization.

Authors:  Solomon Habtemariam
Journal:  Molecules       Date:  2020-03-20       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.